The pace of merger and acquisition activity in the pharmaceutical and biotechnology industries occurs at a steady, unrelenting rate that is often difficult to track. As a business development executive, this creates unique challenges. Each corporate consolidation often eliminates a potential partner. At minimum, business development functions are reorganized or disbanded, making it difficult to identify proper contacts within the merged entity. Frequently, portfolio reviews post-merger alter the therapeutic franchise areas that are strategic to the combined entity. Consolidation also makes it difficult to identify what happened to technologies or products of interest to you that had previously resided in an acquired company. The acquired company’s website quickly disappears along with the visibility and useful information it once provided.
For each of the profiled companies in our database, we have researched its history and identified the major mergers and acquisitions that helped create the entity as it exists today. In addition, beginning with calendar year 2008, we have endeavored to capture as many M&A transactions as possible within the biotechnology and pharmaceutical sectors worldwide, and will continue to expand this database going forward.
Our database of transactions identifies the following elements regarding each M&A event:
- Company Name
- Acquiring Company Name
- Merged Entity Name, if Different
- Year
- Announced Valuation
- Comments
The database can be sorted by each column or element, which allows you to:
- Identify who acquired a particular company so you know whom to contact
- Identify the historical acquisitions for any particular buyer, thereby highlighting their level of M&A activity, the types of companies they are interested in purchasing, the valuations they paid, or who is active in the M&A market in a particular year. This feature would be most helpful if you are interested in selling your company rather than partnering.